These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2942206)

  • 1. Atrial natriuretic factor and generalized edema in rats.
    Velhote VW; Fujihara C; Marcondes M
    Braz J Med Biol Res; 1985; 18(4):481-5. PubMed ID: 2942206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of renal responsiveness to atrial natriuretic peptide in experimental nephrotic syndrome by albumin infusion.
    Abassi Z; Weissman I; Karram T; Goltsman I; Hoffman A; Better OS; Winaver J
    Am J Nephrol; 2013; 38(4):292-9. PubMed ID: 24080549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal natriuretic effects of atrial natriuretic peptide in dogs with alloxan-induced acute pulmonary edema.
    Levy M; Cernacek P
    Clin Invest Med; 1996 Dec; 19(6):435-43. PubMed ID: 8959353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal response to atrial peptides is reduced in experimental nephrosis.
    Perico N; Delaini F; Lupini C; Remuzzi G
    Am J Physiol; 1987 Apr; 252(4 Pt 2):F654-60. PubMed ID: 2952020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunted natriuresis to atrial natriuretic peptide in chronic sodium-retaining disorders.
    Koepke JP; DiBona GF
    Am J Physiol; 1987 May; 252(5 Pt 2):F865-71. PubMed ID: 2953252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vasoactive drugs on the natriuresis of nephrotic rats.
    Okay Y; Ruiz G; Marcondes M
    Braz J Med Biol Res; 1984; 17(1):93-9. PubMed ID: 6478099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of a natriuretic factor in urine of patients with chronic uremia. The absence of the factor in nephrotic uremic patients.
    Bourgoignie JJ; Hwang KH; Ipakchi E; Bricker NS
    J Clin Invest; 1974 Jun; 53(6):1559-67. PubMed ID: 4830222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of uroguanylin, a Peptide with natriuretic activity, in rats with experimental nephrotic syndrome.
    Kikuchi M; Fujimoto S; Fukae H; Kinoshita H; Kita T; Nakazato M; Eto T
    J Am Soc Nephrol; 2005 Feb; 16(2):392-7. PubMed ID: 15590761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atrial natriuretic factor on renal function in rats with nephrotic syndrome.
    Hildebrandt DA; Banks RO
    Am J Physiol; 1988 Feb; 254(2 Pt 2):F210-6. PubMed ID: 2964203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J; Mirzaian Y; Grabensee B
    Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atrial natriuretic peptide in children with nephrotic syndrome].
    Jovanovitsh O; Popovitsh-Rolovitsh M; Radoshevitsh P; Stankovitsh R; Dujitsh A; Gajitsh M; Peco-Antitsh A; Krushchitsh D; Kostitsh M
    Srp Arh Celok Lek; 1995; 123(11-12):291-4. PubMed ID: 16296241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of natriuretic agents, vasoactive agents and of the inhibition of metabolism on sodium handling in the isolated perfused kidney of the nephrotic rat.
    Firth JD; Ledingham JG
    Clin Sci (Lond); 1990 Dec; 79(6):559-74. PubMed ID: 2176943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and renal effects of atrial natriuretic factor in portal hypertensive rats. Potentiation by Phe-Ile-Orn-vasopressin.
    Ganger DR; Gottstein J; Blei AT
    J Pharmacol Exp Ther; 1988 Sep; 246(3):941-5. PubMed ID: 2971104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial peptides and the renal response to hypervolemia in nephrotic rats.
    Keeler R; Feuchuk D; Wilson N
    Can J Physiol Pharmacol; 1987 Oct; 65(10):2071-5. PubMed ID: 2962709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased glomerular atrial natriuretic peptide receptor affinity in experimental nephrotic syndrome.
    Morgan TR; Morgan K; Vaziri ND; Pandian MR
    Life Sci; 1992; 51(5):337-44. PubMed ID: 1320716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related differences in the natriuretic and hypotensive properties of rat atrial extracts.
    Inscho EW; Wilfinger WW; Banks RO
    Endocrinology; 1987 Nov; 121(5):1662-70. PubMed ID: 2959467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation by low sodium intake of glomerular response to cicletanine and atrial natriuretic factor.
    Kalinowski L; Szczepanska-Konkel M; Jankowski M; Angielski S
    Br J Pharmacol; 1997 Jun; 121(4):635-42. PubMed ID: 9208128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
    Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
    Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.